FDA Inspection 1093423 - Regenesis Pharmaceutical Inc. - June 18, 2019

Record Details

This FDA Inspection record concerns Regenesis Pharmaceutical Inc., with an inspection on June 18, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: Regenesis Pharmaceutical Inc.
Inspection Date: June 18, 2019
Product Type: Drugs
Office: Center for Drug Evaluation and Research

Open in Dashboard

ID · 1f1a847c-0ef1-4256-a277-b66b0ac7c64a

Violation Codes10

21 CFR 211.110(a)21 CFR 211.125(a)21 CFR 211.165(a)21 CFR 211.166(a)21 CFR 211.170(b)(1)21 CFR 211.18821 CFR 211.198(a)21 CFR 211.22(d)21 CFR 211.25(a)21 CFR 211.67(b)

Full citation text and observation details available on the Dashboard.